The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novo Nordisk (NVO) shares rose 6% premarket on Thursday, their biggest gain in a month, after a real-world study showed its diabetes drug Ozempic outperformed Eli Lilly’s (NYSE:LLY) older drug ...

In their high-profile competition in the diabetes and obesity markets, Eli Lilly has proven adept in playing catch up with ...

Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could potentially pay out more than $2 billion. There is multidistrict litigation, or an ...

Ozempic has become so embedded in global culture that "Ozempic face" was shortlisted for a prominent dictionary's word of the year in 2025. Ozempic isn't the only drug that mimics the natural GLP-1 ...

Why are Ozempic and Mounjaro facing lawsuits? Here is what patients should know about alleged side effects, current ...